Filed before 2025Filed 20 November 2024
Avenzo Therapeutics, Inc. has sold $386M so far
Avenzo Therapeutics, Inc., a biotech company based in San Diego, CA, has sold $386M so far in its equity round, according to a filing dated 20 November 2024.
Raises filed before 2025 are not checked for a public announcement.
- Filed
- 20 November 2024
- First filed
- 29 September 2022
- Round
- Equity round (amended filing)
- Amount sold
- $386M
- Offering size
- $386M
- Investors so far
- 22
- Based in
- San Diego, CA
- Website
- avenzotx.com
Investors on the board
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
1 director of this company is named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 100% of the 1,434 tracked raises with an amount filed in 2024, and than 99% of the 138 in biotech.
Avenzo Therapeutics, Inc. in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 5 Sep 2025 | New filing | $47.2M | Another raise |
| 20 Nov 2024 | Amended filing | $386M | This raise |
| 26 Mar 2024 | Amended filing | $223M | This raise |
| 29 Sep 2022 | New filing | $31.5M | This raise |
More with SR One Capital on the board
- FORE US Bio Inc.$70.4M
- Rezo Therapeutics, Inc.$68.1M
- ADARx Pharmaceuticals, Inc.$200M
- Dren Bio, Inc.$62.5M
Other unannounced rounds
- DVx Atomic Co.$18.5M
- Aperio Systems, Inc.$1.6M
- Twin Health, Inc.$59M
- Scoring Factory AI Inc.$500K
- Royal & Pelham, Inc.$5.4M
- SPECTRA Holdings US, Ltd.$2.5M
Seen it announced?
Send the link and the check will look at it.